Daniël Verhoef, PhD

Director of Research
1VarmX, Leiden, The Netherlands. 2Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Presentation(s):

• OC 24.3 - VMX-C001 is an effective factor Xa inhibitor reversal agent and displays a favorable pharmacodynamic profile in animal models

  Sunday, July 10, 2022
  3:15 PM – 3:30 PM

• PB1005 - Preclinical safety and toxicokinetics of VMX-C001 - an intravenous bypassing agent for factor Xa inhibitors

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM